<li>Drug Initiation and Monitoring</li>
 <li>Contraindications and Adverse Effects</li>
 <li>Patient Education</li>
<p>

</p>

Drug Initiation and Monitoring Contraindications and Adverse Effects Patient Education

Individualizing Therapy

In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.

Share Individualizing Therapy

Sign up to save your podcasts

Individualizing Therapy

Individualizing Therapy